23andMe Holding Co. (ME) Financials
ME Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 608.2 million | 231.0 million |
2023-09-30 | 801.2 million | 176.0 million |
2023-06-30 | 871.2 million | 195.7 million |
2023-03-31 | 942.6 million | 228.7 million |
ME Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.1 million | 26.4 million |
2023-09-30 | -59.9 million | 23.7 million |
2023-06-30 | -72.1 million | 51.1 million |
2023-03-31 | -48.2 million | 22.2 million |
ME Net Income
No data available :(
ME Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 242.4 million | - | 78.8 million |
2023-09-30 | 256.4 million | - | 81.0 million |
2023-06-30 | 314.4 million | - | 83.2 million |
2023-03-31 | 386.8 million | - | 85.3 million |
ME Shares Outstanding
ME Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.0 million | 41.7 million | 35.6 million | 21.6 million |
2023-09-30 | 2.8 million | 54.6 million | 29.9 million | 11.0 million |
2023-06-30 | 2.7 million | 62.3 million | 55.4 million | 15.3 million |
2023-03-31 | 3.3 million | 60.7 million | 26.8 million | 21.8 million |
ME Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 44.7 million | 24.8 million |
2023-09-30 | 50.0 million | 28.3 million |
2023-06-30 | 60.9 million | 30.2 million |
2023-03-31 | 92.4 million | 52.4 million |
ME
Price: $0.46
52 week price:
Earnings Per Share: -1.11 USD
P/E Ratio: -0.96
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.6 million
Market Capitalization: 231.3 million